SMARCA4:癌症治疗中的承诺和挑战
Wei Ye1, Ding An2, Wen-Bin Ou3
1Department of Biopharmaceutics, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, China.
Cancer letters
|May 21, 2025
概括
SMARCA4突变与癌症预后不佳和治疗耐药性有关. 针对SMARCA4合成致命合作伙伴提供了一个有希望的治疗途径,但组合策略对于改善患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在癌症中,SWI/SNF复合体亚单元ATPase 4 (SMARCA4) 经常发生突变,与预后不佳相关.
- 在染色体重塑和基因表达中,SMARCA4的作用至关重要,但其精确的致癌机制尚未完全理解.
- 患有SMARCA4突变的患者对标准癌症治疗反应有限.
研究的目的:
- 综合研究SMARCA4在癌症发展中的生物学功能和机制.
- 确定SMARCA4作为精密瘤学的潜在生物标志物和治疗标.
- 探索SMARCA4缺乏瘤的新疗法策略.
主要方法:
- 对SMARCA4在基因调节中的作用,细胞过程 (铁,自,脂质代谢,氧化应激) 和癌症的现有文献的审查.
- 与SMARCA4突变相关的患者预后和治疗反应的临床数据的分析.
- 探索针对SMARCA4及其相关途径的新兴治疗方法.
主要成果:
- SMARCA4突变与预后不佳和对各种癌症疗法的耐药性有关.
- 在基本的细胞过程中,SMARCA4的参与表明它在瘤发生过程中扮演了复杂的角色.
- 针对SMARCA4的合成致命合作伙伴是开发精确疗法的重大突破.
结论:
- 在瘤学中,SMARCA4是一个关键的治疗标和生物标志物.
- 针对SMARCA4的单一疗法存在局限性;联合策略对于克服耐药性和提高疗效至关重要.
- 对SMARCA4缺乏癌症的组合疗法的进一步研究对于临床转化至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K